U.S. OKs Novartis Gleevec to reduce recurring cancer (Reuters)

[riky]

U.S. OKs Novartis Gleevec to reduce recurring cancer
    (Reuters)

 


Reuters - U.S. health regulators have approved Novartis' drug Gleevec to reduce the risk of cancer recurring in patients with a rare type of stomach cancer, Novartis said on Friday.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20081220/hl_nm/us_fda_novartis